Related references
Note: Only part of the references are listed.Histological recurrence of autoimmune liver diseases after living-donor liver transplantation
Hironori Haga et al.
HEPATOLOGY RESEARCH (2007)
Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis
Konstantims N. Lazaridis et al.
HEPATOLOGY (2007)
Prevalence and predictors of Esophageal varices in patients with primary biliary cirrhosis
Cynthia Levy et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis
Dimitrios P. Bogdanos et al.
HEPATOLOGY (2007)
Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis
Ayako Suzuki et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis
Minoru Nakamura et al.
HEPATOLOGY (2007)
Clinical features of symptomatic primary biliary cirrhosis initially complicated with esophageal varices
Yosuke Murata et al.
JOURNAL OF GASTROENTEROLOGY (2006)
Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients
Pieter C. J. ter Borg et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort
DEJ Jones et al.
GUT (2006)
Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis
C Rigamonti et al.
GUT (2006)
Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid
A Parés et al.
GASTROENTEROLOGY (2006)
Medical progress: Primary biliary cirrhosis
MM Kaplan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Similar anti-mitochondrial antibody reactivity profiles in familial primary biliary cirrhosis
Y Hayase et al.
HEPATOLOGY RESEARCH (2005)
Evaluation of fatigue in US patients with primary biliary cirrhosis
CM Stanca et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis
M Nakamura et al.
JOURNAL OF HEPATOLOGY (2005)
Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?
B Bressler et al.
GUT (2005)
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis
C Corpechot et al.
GASTROENTEROLOGY (2005)
A case of latent primary biliary cirrhosis
K Tsuji et al.
HEPATOLOGY RESEARCH (2004)
Prevalence of antimitochondrial antibody in Japanese corporate workers in Kanagawa prefecture
M Shibata et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Do Antinuclear Antibodies in Primary Biliary Cirrhosis Patients Identify Increased Risk for Liver Failure?
Wei-Hong Yang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Earlier recurrence of esophageal varices, following therapy, in patients with primary biliary cirrhosis (PBC) compared with non-PBC patients
E Takeshita et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort
MI Prince et al.
GUT (2004)
Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis
RE Poupon et al.
JOURNAL OF HEPATOLOGY (2003)
Esophagogastric varices as a prognostic factor for the determination of clinical stage in patients with primary biliary cirrhosis
E Takeshita et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: Follow-up for up to 28 years
M Prince et al.
GASTROENTEROLOGY (2002)
Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis
A Shibuya et al.
HEPATOLOGY (2002)
Long-term prognosis of primary biliary cirrhosis (PBC) in Japan and analysis of the factors of stage progression in asymptomatic PBC (a-PBC)
T Nakano et al.
HEPATOLOGY RESEARCH (2002)
The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis
C Corpechot et al.
HEPATOLOGY (2000)
Hyperplastic liver nodules associated with early-stage primary biliary cirrhosis mimicking hepatocellular carcinoma
M Abe et al.
DIGESTIVE DISEASES AND SCIENCES (2000)
Share Paper
